PRN: Global Cryoablation Devices Market to Grow at a CAGR of 6% by 2021 - Paradigm Shift Toward Minimally Invasive Procedures

17/lug/2017 20:15:12 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Cryoablation Devices Market to Grow at a CAGR of 6% by 2021 - Paradigm Shift Toward Minimally Invasive Procedures


DUBLIN, July 17, 2017 /PRNewswire/ --

The "Global Cryoablation Devices Market 2017-2021" report has been added to Research and Markets' offering.


The global cryoablation devices market to grow at a CAGR of 6.10% during the period 2017-2021.

The report, Global Cryoablation Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is paradigm shift toward minimally invasive procedures. Cryoablation is considered as one of the effective and minimally invasive procedures, which uses frigid temperatures to kill cancer cells while preserving the surrounding tissues. According to reports published by Galil Medical, doctors all over the world have been using cryoablation to treat different types of cancer.

According to the report, one driver in the market is safe and effective treatment for AVNRT patients. AVNRT is the second most common form of paroxysmal recurrent tachycardia in children. RA ablation has become the first-line therapy for AVNRT, with high success and low recurrence rates. However, a definite risk of damage to the atrioventricular (AV) node still exists. Cryoablation procedure provides a distinct advantage adjacent to the AV node for para-Hisian pathways and difficult cases of AVNRT, which cannot be performed by conventional RA ablation.

Further, the report states that one challenge in the market is high cost of cryoablation devices and procedures. The cost of cryosurgeries involving cryoablation devices is more than that of the RF procedures. AF ablation requires the use of expensive technology and equipment. Physicians have considerable latitude in equipment choice. The average Medicare reimbursement is $10,338 for uncomplicated AF ablations. The treatment of cardiac arrhythmia can be resolved either by the RF ablation or by the cryoablation procedure. 

Key vendors

  • Medtronic
  • Galil Medical
  • CooperSurgical

Other prominent vendors

  • ACS Myanmar Medical
  • AtriCure
  • BVM Medical
  • CPSI Biotech
  • ForTec Medical
  • HealthTronics
  • RA Distribution
  • Solution Medical

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by product

PART 07: Market segmentation by end-user

PART 08: Geographical segmentation

PART 09: Decision framework

PART 10: Drivers and challenges

PART 11: Market trends

PART 12: Vendor landscape

PART 13: Key vendor analysis

For more information about this report visit

Media Contact:

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


blog comments powered by Disqus è un servizio offerto da Factotum Srl